logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
5/23/2018 6:46:15 AM Merck Says Pivotal Phase 3 KEYNOTE-407 Trial Investigating KEYTRUDA Met Dual Primary Endpoints Of OS And PFS
5/22/2018 2:49:52 PM Merck Declares Quarterly Dividend Of $0.48, Payable July 9/ Record June 15
5/22/2018 2:28:52 PM Merck & Co Inc. (MRK) Declares $ 0.48 Dividend for Q3 18, Record Date 6/15/2018
5/8/2018 6:46:21 AM AstraZeneca And Merck: LYNPARZA Tablets Receive EU Approval For Platinum-Sensitive Relapsed Ovarian Cancer
5/7/2018 7:04:00 AM Veeva Announces Merck’s Expanded Use Of Veeva CRM For Latin America And Asia Pacific
5/3/2018 4:23:20 PM Moderna Therapeutics And Merck Announce Expansion Of Their 2016 MRNA Cancer Vaccines Collaboration
5/3/2018 6:49:05 AM Merck Says Phase 3 KEYNOTE-407 Trial On KEYTRUDA Met A Pre-specified Secondary Endpoint
5/1/2018 6:46:27 AM Merck Q1 Worldwide Sales $10.0 Bln, Up 6%
4/30/2018 6:46:55 AM Merck Says FDA Accepted For Review Supplemental Biologics License Application For KEYTRUDA
4/23/2018 4:36:02 PM Merck: EMA Validates Type II Variation For KEYTRUDA In Combination With Pemetrexed And Platinum Chemotherapy
4/17/2018 8:31:27 AM Merck Begins Two Phase 3 Studies Of PCV-15 (V114) For Prevention Of Pneumococcal Disease